Evidence map›Paper›PMID 33987739›Full record

ArticleAAPS PharmSciTech2021

Application of Design of Experiments® Approach-Driven Artificial Intelligence and Machine Learning for Systematic Optimization of Reverse Phase High Performance Liquid Chromatography Method to Analyze Simultaneously Two Drugs (Cyclosporin A and Etodolac) in Solution, Human Plasma, Nanocapsules, and Emulsions.

Syed Nazrin Ruhina Rahman, Oly Katari, Datta Maroti Pawde, Gopi Sumanth Bhaskar Boddeda, Abhinab Goswami, Srinivasa Rao Mutheneni, Tamilvanan Shunmugaperumal

Abstract read
PubMed Publisher
In one paragraph

Article in AAPS PharmSciTech, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.1field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Syed Nazrin Ruhina RahmanDepartments of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Sila Katamur, Changsari, Kamrup, Assam, 781101, India.
Oly KatariDepartments of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Sila Katamur, Changsari, Kamrup, Assam, 781101, India.
Datta Maroti PawdeDepartments of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Sila Katamur, Changsari, Kamrup, Assam, 781101, India.
Gopi Sumanth Bhaskar BoddedaBioinformatics Group, Applied Biology Division, CSIR-Indian Institute of Chemical Technology, Tarnaka, Hyderabad, Telangana, 500007, India.
Abhinab GoswamiDepartments of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Sila Katamur, Changsari, Kamrup, Assam, 781101, India.
Srinivasa Rao MutheneniBioinformatics Group, Applied Biology Division, CSIR-Indian Institute of Chemical Technology, Tarnaka, Hyderabad, Telangana, 500007, India.
Tamilvanan ShunmugaperumalDepartments of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Sila Katamur, Changsari, Kamrup, Assam, 781101, India. tamilvanan1@yahoo.co.in.ORCID http://orcid.org/0000-0001-7338-3207
National Institute of Pharmaceutical Education and Research · INIndian Institute of Chemical Technology · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objectives of current investigation are (1) to find out wavelength of maximum absorbance (λ

Indexed as

Machine LearningNeural Networks, ComputerAlgorithmsAntifungal AgentsArtificial IntelligenceChromatography, High Pressure LiquidChromatography, Reverse-PhaseCyclosporineEmulsionsEtodolacHumansNanocapsulesResearch DesignAntifungal AgentsCyclosporineEmulsionsEtodolacNanocapsulesanalytical quality by designartificial neural networkcyclosporin Aetodolacface-centered central composite designhuman plasmaLevenberg–Marquardt algorithm

Identifiers

PMID33987739
OpenAlexW3160804642

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.